Category Archives: Biotechnology

Cryptococcosis Drugs Market Share and Competitive Dynamics | Gilead Sciences, Merck, Pfizer, Johnson & Johnson

Cryptococcosis Drugs Market: In 2024, the market was valued at around USD 5.82 billion. It is projected to reach approximately USD 8.59 billion by 2031, with a CAGR of 5.50% from 2024 to 2031. Cryptococcosis is a fungus caused by Cryptococcus neoformans and Cryptococcus gattii that mostly affects the central nervous system and lungs. People […]

Companion Animal Postoperative Pain Management Therapeutics Market Share and Competitive Dynamics | Zoetis, Merck, Elanco, Boehringer Ingelheim, Vetoquinol

Companion Animal Postoperative Pain Management Therapeutics Market: The market size was about USD 133.5 million in 2023. It is expected to grow to approximately USD 671.4 million by 2030, with a CAGR of 6.5% from 2024 to 2032. The demand for postoperative pain relievers is increasing as the number of pet surgical operations, particularly orthopaedic […]

Cold Pressed Citrus Oil Market Share and Competitive Dynamics | CitroBio, Now Foods, Citrus and Allied Essences, Young Living, doTERRA

Cold Pressed Citrus Oil Market: In 2023, the market was valued at around USD 3.90 billion. It is anticipated to reach approximately USD 5.56 billion by 2030, with a CAGR of 5.21% from 2024 to 2030. Cold pressed citrus oil has grown in leaps and bounds, particularly used in the beauty and wellness industry. The […]

Acute Ischemic Stroke Drugs Market Share and Competitive Dynamics | Boehringer Ingelheim, Genentech, Merck, AstraZeneca, Pfizer

Acute Ischemic Stroke Drugs Market: The market size was about USD 13.01 billion in 2023. It is expected to grow to approximately USD 14.0 billion by 2032, with a CAGR of 4.6% from 2023 to 2032. The posterior circulation, the anterior circulation, or both can be affected by acute ischemic stroke (AIS). The internal carotid […]

Small Molecule API Market Share and Competitive Dynamics | Lonza, Teva Pharmaceuticals, Dr. Reddy’s Laboratories, Pfizer, Amgen

Small Molecule API Market: In 2023, the market was valued at approximately USD 194.96 billion. It is projected to reach around USD 331.56 billion by 2034, with a CAGR of 5.45% from 2024 to 2034. An organic substance having a molecular weight of less than 1 nm that aids in the regulation of biological processes […]

Recombinant Vector Vaccines Market Share and Competitive Dynamics | Merck, GlaxoSmithKline, AstraZeneca, Johnson & Johnson, Novavax

Recombinant Vector Vaccines Market: In 2023, the market was valued at around USD 10.14 billion. It is anticipated to reach approximately USD 34.18 billion by 2034, with a CAGR of 11.68% from 2024 to 2034. The global recombinant vector vaccine market is being driven by rapid advances in molecular biology and genetic engineering. During the […]

Clarithromycin Tablets Market Share and Competitive Dynamics |Abbott, Mylan, Sandoz, Teva Pharmaceuticals, Aurobindo Pharma

Clarithromycin Tablets Market: The market size was about USD 1.91 billion in 2023. It is expected to grow to approximately USD 2.99 billion by 2028, with a CAGR of 9.4% from 2024 to 2028. The major factors that are expected to fuel the market growth include the increased count of skin and bacterial infections, R&D […]

Chlorpheniramine Maleate Market Share and Competitive Dynamics: Pfizer, Sanofi, Johnson & Johnson, GlaxoSmithKline, Mylan

Chlorpheniramine Maleate Market: In 2023, the market was valued at approximately USD 514.9 million. It is projected to reach around USD 848.1 million by 2032, with a CAGR of 5.7% from 2024 to 2032. The high incidence of allergic conditions such as rhinitis has been attributed to the positive growth of the market. Chlorpheniramine maleate […]

Azithromycin Market Share and Competitive Dynamics: Pfizer, Teva Pharmaceuticals, Sun Pharma, Mylan, Sandoz

In 2023, the global azithromycin market was valued at approximately USD 7.01 billion. It is projected to grow to around USD 10.33 billion by 2030, reflecting a compound annual growth rate (CAGR) of 5.68% from 2024 to 2030. The major factor that is driving the market growth includes the increasing prevalence of bacterial infection. Azithromycin […]

Alpha Galactosidase Market Share and Competitive Dynamics: Forecast Insights to 2031

The global Alpha Galactosidase market was valued at approximately USD 2.2 billion in 2023 and is projected to reach around USD 3.5 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031. The prevalence of flatulence and bloating varies with sex and age. Unhealthy eating habits among the […]